Atossa Genetics Shares Move Higher Following News Co. to Demonstrate ForCYTE Test at Breast Cancer Symposium 2013
September 06, 2013 at 09:00 AM EDT
Atossa Genetics, Inc. (NASDAQ: ATOS ), The Breast Health Company(TM), will display its ForeCYTE Breast Health Test at the 7th annual Breast Cancer Symposium from September 7 through September 9, 2013 in San Francisco. Atossa's exhibit will be located in Booth 33 at the San Francisco Marriott Marquis -- Golden Gate Hall. The ForeCYTE Breast
